about
Hyperspectral imaging of nanoparticles in biological samples: simultaneous visualization and elemental identifcationFeasibility and cost of a medical student proxy-based mobile teledermatology consult service with Kisoro, Uganda, and Lake Atitlán, Guatemala.Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infectionNanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction.A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular responseFidgetin-Like 2: A Microtubule-Based Regulator of Wound HealingReversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide.Topically applied NO-releasing nanoparticles can increase intracorporal pressure and elicit spontaneous erections in a rat model of radical prostatectomy.Trichophyton rubrum is inhibited by free and nanoparticle encapsulated curcumin by induction of nitrosative stress after photodynamic activation.Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent.TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus.Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses.Nitric oxide releasing nanoparticles for treatment of Candida albicans burn infections.Nitric Oxide-Releasing Nanoparticles Prevent Propionibacterium acnes-Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response.An Unusual Association between Sweet's Syndrome and Metastatic Papillary Follicular Thyroid CarcinomaSustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter ModelAntimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogensThe use of chitosan to damage Cryptococcus neoformans biofilms.Nitric oxide therapy for dermatologic disease.New biomaterials for the sustained release of nitric oxide: past, present and future.The growing role of nanotechnology in combating infectious disease.Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections.Nanotechnology as a therapeutic tool to combat microbial resistance.Geminate rebinding in trehalose-glass embedded myoglobins reveals residue-specific control of intramolecular trajectories.Antimicrobial photodynamic therapy: an effective alternative approach to control fungal infections.Biodegradable chitosan nanoparticles in drug delivery for infectious disease.Psoriasis-associated fatigue: pathogenesis, metrics, and treatment.Nitric oxide generating/releasing materials.Nitric oxide as a surgical adjuvant.Development and therapeutic applications of nitric oxide-releasing materials.Pediatric dermatology training during residency: a survey of the 2014 graduating residents.Bensal HP Treatment for Burn and Excision Wounds: An In-Vivo Assessment of Wound Healing Efficacy and Immunological Impact.S-nitrosocaptopril nanoparticles as nitric oxide-liberating and transnitrosylating anti-infective technology.Exogenous nitric oxide prevents cardiovascular collapse during hemorrhagic shock.Sustained release nitric oxide from long-lived circulating nanoparticles.Amphotericin B releasing nanoparticle topical treatment of Candida spp. in the setting of a burn wound.Nitric oxide-releasing nanoparticles accelerate wound healing in NOD-SCID mice.Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites.Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection.Biafine topical emulsion accelerates excisional and burn wound healing in mice.
P50
Q26342353-70348343-DE15-49AB-A4BB-4C68A22E98D7Q33442395-D0DF7578-1EE8-4B71-8BB0-08E9CC552F57Q33516015-5938D7B9-E4BE-4A7D-B62C-2EA457636874Q33829654-74057287-4318-4E37-BF7D-81AC754E2A65Q34141284-B243AB4F-0EFA-43BB-BFE7-EAE6CDC2AC06Q34466491-3EAB2765-3F7D-4C02-8E0B-B944667E4D28Q34501963-FE540A8E-A62B-4462-8017-EA88C8A922A2Q34641767-6B5FA020-9896-45F7-8CDC-5041FBF64A20Q35585147-E7BEA114-B7DB-4605-A28D-39E21B6A9A50Q35705744-FC977B3B-AD7B-4C04-8F6F-48F88F4B73F6Q35858608-005CB10E-4AF5-4063-9791-01B97E9F4E3CQ35914150-39F0A6E1-2280-4E19-BD10-19D2EA38FD8BQ36018405-66F1A35F-530D-41B4-9E25-F5BA7C95392DQ36269182-AEBC47CF-133A-4BD4-9081-7383751C01ABQ36640558-93B89D1C-FCB5-4402-B0E7-9F0859FE7E27Q36730043-992A1CBD-8B69-4C42-8C4A-6ED2D6AC9DDFQ36780824-2CF78A7F-44C0-43C1-A425-8240433FADEFQ37438897-BBB2C270-C55F-4DD4-A8B1-96D02118AFFDQ37474339-B8ABD65B-A71B-413D-964D-14FAC9B047D9Q37575595-CCBA9D2B-2BD1-4B1C-8667-B73786ABC9B9Q37932991-483D626A-42EF-4332-BB31-2B1BDBE51827Q38105519-FB9C09A1-C42B-4426-BC5B-0299B3A4C4B0Q38124665-BEB8EBC8-BF8A-4E3E-9B53-3311DD6F722BQ38293211-2E07D50E-62EA-4842-92A7-CDCEDD5D9BE4Q38395485-FE3E380A-8A19-4E1C-8A4E-632C7BBE1D22Q38501659-2CC7960A-5241-44BD-84BD-D15A641D944EQ38751632-CB1A8DEA-A9E1-4963-A827-8613D5A58CCDQ38910851-D827F632-CCB1-485A-ABA3-FE7CE296E03EQ38979827-0A66FAA1-39BF-4BD0-9D53-843442571198Q38979831-1E5B3A9D-FB48-42EE-81E4-E418C1135473Q39024381-69387571-A12C-42C2-A9C8-301ACD4FEFD8Q40905409-F0C8B4C5-0E90-470C-B944-4FB5700902ABQ41626441-A8020009-912E-4A89-8BAC-F68183A87F44Q41784343-976058B0-479E-4EAE-8A41-48B64BC1096CQ42099521-DAB6CF6E-33FD-42AE-AC75-2EA26D6413C3Q42258855-E6B914E2-8436-477E-A5F2-4F3DF10C5BE0Q44811415-77E60F52-BF49-4592-99B4-D9EF650C8821Q46611217-CFC444EE-8984-4D0C-850D-16A0409AC0C7Q47959702-6C01E38F-122F-4A17-914B-8A999FC44D82Q50997216-CC28B1DB-1E7D-4C0F-A51D-79FFEEC33392
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Adam J. Friedman
@ast
Adam J. Friedman
@en
Adam J. Friedman
@es
Adam J. Friedman
@nl
type
label
Adam J. Friedman
@ast
Adam J. Friedman
@en
Adam J. Friedman
@es
Adam J. Friedman
@nl
prefLabel
Adam J. Friedman
@ast
Adam J. Friedman
@en
Adam J. Friedman
@es
Adam J. Friedman
@nl
P214
P106
P1153
7401879723
P21
P214
P31
P496
0000-0001-8925-1620
P734
P735
P7859
lccn-n2013182639